UFA Challenge, pancreatic cancer stage IV.

[Guest guest]

I wanted to reply to both this posting and previous discussing about the UFA

challenge intensive high-dose lipid regimen.

This approach uses very high doses of potent lipids and other over-the counter

agents, and, as mentioned, is limited in that it takes a patient in

active status to carry out. To achieve the very high serum levels needed, this

requires fasting most of the day for most days of a 6-day period, and is most

appropriate for a patient with a cancer diagnosis having limited prospects for

standard treatment (like stage IV pancreatic cancer) but without major health

limitations. Because it uses all over-the-counter agents, it has been possible

to make rapid progress, with dose escalation and improvements after each

clinical use. (Typical clinical trials take years of clearances and

preparations to get to a clinical outcome). The goal is to reproduce

pre-clinical study results showing 100% tumor kill for each cancer type. The

last patient to use this had two successive 50% drops in marker values, and only

minor, transient toxicities, but consistent such results will of course be

needed, as well as getting marker values down to zero for this patient, for a

reliable indication that this approach is effective.

Let me publicly thank for helpful scientific communcations dating back

to 2003, including a link to a paper indicating that certain non-lipid agents

can modulate the anticancer properties of lipids. It has turned out indeed that

two adjunct agents have sharp potentiating effects, and these are both now

included. Some of the limitations that mentioned remain, most notably

the need for the patient to be in active condition to pursue this, but others

have been solved - there is one very good source of concentrated DHA/EPA with

very low vitamin E content, which I had verified in an independent lab test.

This is an intensive 6-day regimen, which, if successful, will yield major

response, just like chemotherapy, as measured by tumor markers, scans, symptoms,

etc., within a month following. There would be a plus for melanoma, certain

leukemias, brain tumors, and tumors in the intestinal or peritoneal regimen,

including pancreatic cancer. This regimen is under test in a more limited form

for one cancer type only at a major medical center -- I am a co-investigator on

this clinical study.

Because pancreatic cancer is aggressive with poor propsects for standard

treatment, some such aggressive investigational treatment approach would be

appropriate. Helen, feel free to email me if you'd like more information

(davids@...). I would suggest in general that your friend's mother should

consider trying some investigational regimen, whether standard or non-standard,

with some objective basis for potential efficacy . If she were interested in

trying this and able to do so, I would certainly be glad to report progress of

that test to this list. -

-Helen Wang <dingyung49@...> wrote:

>

> Hi, ,

>  

>     My best friend's mother went to hospital had surgery of her gallbladder

and was told she also had pancreatic cancer stage IV. Her family members

considered it was a death sentence.  What do you think cesium chloride? powerful

anti-cancer stuff?  Helen

>